US Patent Issued to VORONOI, VORONOIBIO on April 22 for "N-containing heteroaryl derivative and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer" (South Korean Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,121, issued on April 22, was assigned to VORONOI Inc. (Incheon, South Korea) and VORONOIBIO Inc. (Incheon, South Korea).

"N-containing heteroaryl derivative and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer" was invented by Seo Hyun Jo (Seoul, South Korea), Hua Li (Incheon, South Korea), Hee Sun Ryu (Incheon, South Korea), Hwan Kim (Seoul, South Korea), Ji Yoon Seok (Incheon, South Korea), Sun Hwa Lee (Incheon, South Korea), Jung Beom Son (Incheon, South Korea) and Nam Doo Kim (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an N-containing he...